After Change Up Top, Syntonix Inks Boehringer Ingelheim Deal Worth Up to $63M

News | 10. 24. 2005

Syntonix Pharmaceuticals

After a management change over the summer, drug formulation and delivery company Syntonix Pharmaceuticals Inc. has kicked off autumn with a collaboration with Boehringer Ingelheim GmbH that could bring in as much as $63 million.